Transhumanism tends to overpromise. The movement’s public facing claims have frequently run years or decades ahead of the engineering realities they invoke, and the gap between aspiration and actual technology has given critics a permanent supply of ammunition. John Joao Teixeira’s “The Cyborg’s Brain,” published in January 2026, attempts to close this gap from the inside: not by dismissing the transhumanist agenda, but by demanding that it reckon honestly with what current systems can and cannot do.

Teixeira is an AI systems researcher, and the book reads that way. It is less a philosophical treatise than a technical audit of transhumanist enhancement claims measured against current capabilities. The analysis is systematic, sometimes blunt, and occasionally undermines its own conclusions by applying standards that no emerging technology has ever met at early stages. But its central contribution, that the transhumanist discourse has decoupled from what the relevant engineering actually shows, is a fair and necessary one.

Teixeira’s Central Claim

The book’s core argument is that transhumanist ideals require three categories of capability that current digital and AI systems do not possess: reliable high-bandwidth brain-computer integration, computational architectures that can support genuine cognitive enhancement rather than task automation, and identity-preserving continuity across biological and digital substrates.

Teixeira is careful to note that these are engineering problems, not logical impossibilities. He is not arguing that transhumanist enhancement is permanently out of reach. He is arguing that the current state of the field does not justify the confidence that transhumanist advocates frequently express, and that the gap between current capabilities and what enhancement ideals require is larger than public discourse acknowledges.

The structure of the book mirrors this: three substantive sections, each addressing one of the three capability categories, followed by a shorter section on what a more grounded transhumanist agenda would look like.

The Gap Between Promise and Implementation

Teixeira opens with an inventory of what actually exists. The most clinically advanced brain computer interface systems in 2025-2026, including the Neuralink N1 implant with its 1,024-electrode array and the Paradromics Connexus device with over 1,600 electrodes, have demonstrated meaningful results for specific medical applications: motor restoration, speech decoding, vision restoration in some patients.

What they have not demonstrated is cognitive enhancement in the sense transhumanist literature describes. Transhumanist claims about BCIs tend to invoke augmented memory, accelerated learning, direct knowledge transfer, and seamless human-machine integration. The current devices achieve none of these. They solve specific information translation problems between neural signals and digital outputs. That is valuable medical engineering. It is not the merger of biological and digital cognition that enhancement rhetoric implies.

Teixeira makes this distinction carefully and without contempt. The Neuralink human trials represent a genuine advance in the rehabilitation of severe motor disabilities. The clinical achievement does not validate the enhancement claim that the same technology roadmap will eventually produce cognitive augmentation. These are different claims requiring different evidence.

Where AI Systems Fall Short

The second section of the book focuses on AI, and here Teixeira is more pointed. The transhumanist argument for AI-assisted cognitive enhancement typically runs: AI systems will become capable enough that integrating them with biological cognition will produce hybrid intelligence exceeding either component alone.

Teixeira identifies several problems with this argument. First, current AI systems are profoundly narrow. They excel within well-defined task domains and fail in unpredictable ways when tasks shift. A system that can outperform humans on text generation does not generalize to spatial reasoning, physical world navigation, or real-time adaptation to novel situations in ways that would be useful for cognitive enhancement.

Second, the integration problem is unsolved. Coupling AI computation with biological cognition requires a communication channel, and that channel is the brain computer interface problem described above. There is no current architecture for running AI inference as a real-time augmentation layer for biological neural processes. The latency, bandwidth, and interpretability requirements are all unsatisfied simultaneously.

Third, “enhancement” is undefined in most transhumanist uses. Enhancement relative to what baseline, for what tasks, at what cost to other cognitive functions? Teixeira argues that this definitional vagueness allows transhumanist advocates to claim credit for any AI advance while remaining insulated from any specific engineering failure.

The BCI Problem

Teixeira’s most technically detailed section concerns the brain computer interface challenge. The core issue is biological: current electrode technologies, including both rigid silicon arrays and the newer flexible graphene-mesh designs, produce neural signal data from a small fraction of the total neurons in any given brain region. Even the most electrode-dense current devices sample on the order of thousands of neurons in a brain with roughly 86 billion.

Scaling electrode density to cover a meaningfully large neural population is not blocked by a single engineering constraint. It involves simultaneous challenges in biocompatibility, signal processing, power delivery, heat dissipation, and long-term stability. Current flexible implants show improved long-term biocompatibility relative to rigid devices, with stable recordings demonstrated at 24 months in some systems. But 24 months of stable recording from a few thousand neurons is a different scale of achievement from the kind of dense, large-area coverage that cognitive augmentation would require.

Teixeira is not pessimistic about long-term progress. He is pointing out that the gap between “electrode arrays work in limited regions for medical applications” and “brain computer interfaces support cognitive enhancement” is an engineering distance that has not been acknowledged clearly in transhumanist writing.

What the Book Gets Right

Teixeira’s most valuable contribution is his insistence that technology readiness levels matter. Enhancement claims that are valid at TRL 1 (basic principle observed) are not valid at TRL 4 or TRL 7. The transhumanist literature has consistently used aspirational claims at TRL 1-2 to justify policy positions, ethical frameworks, and social programs that would only be appropriate if the technology were at TRL 7-9.

The International AI Safety Report 2026 makes a related point about regulatory readiness. Governance frameworks built for technologies that do not yet exist may be inappropriate for the technologies that actually emerge. Teixeira’s argument applies the same logic to the enhancement claims themselves.

His reading of the neuroscience literature is also generally accurate. He does not misrepresent what BCI devices currently do. He does not claim that progress is impossible. He identifies specific technical gaps and asks why they are not more prominently acknowledged in transhumanist discourse. These are fair questions.

A More Grounded Transhumanism

The book’s final section attempts to sketch what transhumanism would look like if it were more precisely matched to what current and near-future technology actually enables. Teixeira’s version is more modest: assistive technologies for cognitive and sensory deficits, well-characterized AI tools for specific problem domains, and BCI systems for medical applications with carefully bounded enhancement claims.

This is not what most transhumanists would recognize as their program. It is closer to what might be called rehabilitation-centric augmentation. Teixeira’s position is that this is where the technology is, and claiming more is an obstacle to honest evaluation of real progress.

Whether transhumanism should aspire to more than its current engineering can deliver is a question the book does not resolve. Aspirational visions have historically driven engineering progress. The question is whether the aspiration is calibrated to the real state of knowledge or whether it runs so far ahead that it becomes detached from any meaningful feedback from the technology itself.

Future Outlook

Teixeira’s book will frustrate readers who think the technical challenges he identifies are minor or temporary. They are not minor. Each of the three capability gaps he identifies represents a research agenda of years to decades, not months. Whether his technical assessments will still be correct in five years is genuinely uncertain, but they are accurate for the current moment.

The more productive reading of “The Cyborg’s Brain” is as a baseline document. When the field does close one of these gaps, Teixeira’s formulation of what needs to happen will provide a clear reference point for evaluating whether the gap is actually closed or just partially addressed. That is a service to the field regardless of how quickly the relevant engineering matures.

---

Official Sources

• Teixeira, J.J. (2026). “The Cyborg’s Brain: The Feasibility of Transhumanist Ideals.” Published January 15, 2026.
• Musk, E. et al. / Neuralink (2026). Clinical trial results, 21 patients across 4 countries. Neuralink Human Trials 2026
• Paradromics (2026). Connexus FDA approval for speech restoration. 1,600+ electrode device. Paradromics Connexus overview
• Salatino, J.W. et al. (2017). “Glial responses to implanted electrodes in the brain.” Nature Biomedical Engineering 1(11): 862–877. DOI: 10.1038/s41551-017-0154-1
• Flexible implant biocompatibility research overview: Flexible Brain Implants Breakthrough
• International AI Safety Report 2026. Applied to BCI and WBE governance: Full analysis